Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20511418 | 0.84 | MEN1 (0.62) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL515257 | 0.82 | NPC1 (0.61) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1252918 | 0.82 | KMT2A (0.64) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL20495063 | 0.81 | MEN1 (0.59) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL513780 | 0.81 | PTPN1 (0.61) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9700935 | 0.81 | KMT2A (0.58) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10341802 | 0.81 | NPC1 (0.58) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL514347 | 0.80 | PTPN1 (0.64) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL515116 | 0.80 | MEN1 (0.66) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11281655 | 0.79 | ALDH1A1 (0.56) | CYP2C19POLBNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009029625-A1 | 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009029625-A1 | 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |